"Hemochromatosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
| Descriptor ID |
D006432
|
| MeSH Number(s) |
C16.320.565.618.337 C18.452.565.500.480 C18.452.648.618.337
|
| Concept/Terms |
Hemochromatosis- Hemochromatosis
- Bronzed Cirrhosis
- Bronzed Cirrhoses
- Cirrhoses, Bronzed
- Cirrhosis, Bronzed
- Diabetes, Bronze
- Haemochromatosis
- Haemochromatoses
- Von Recklenhausen-Applebaum Disease
- Disease, Von Recklenhausen-Applebaum
- Diseases, Von Recklenhausen-Applebaum
- Recklenhausen-Applebaum Disease, Von
- Recklenhausen-Applebaum Diseases, Von
- Von Recklenhausen Applebaum Disease
- Von Recklenhausen-Applebaum Diseases
- Bronze Diabetes
- Iron Storage Disorder
- Disorder, Iron Storage
- Disorders, Iron Storage
- Iron Storage Disorders
- Storage Disorder, Iron
- Storage Disorders, Iron
- Pigmentary Cirrhosis
- Cirrhoses, Pigmentary
- Cirrhosis, Pigmentary
- Pigmentary Cirrhoses
- Troisier-Hanot-Chauffard Syndrome
- Syndrome, Troisier-Hanot-Chauffard
- Syndromes, Troisier-Hanot-Chauffard
- Troisier Hanot Chauffard Syndrome
- Troisier-Hanot-Chauffard Syndromes
- Hemochromatoses
- Hemochromatose
Familial Hemochromatosis- Familial Hemochromatosis
- Familial Hemochromatoses
- Hemochromatoses, Familial
- Hemochromatosis, Familial
- Primary Hemochromatosis
- Genetic Hemochromatosis
- Genetic Hemochromatoses
- Hemochromatoses, Genetic
- Hemochromatosis, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Hemochromatosis".
Below are MeSH descriptors whose meaning is more specific than "Hemochromatosis".
This graph shows the total number of publications written about "Hemochromatosis" by people in this website by year, and whether "Hemochromatosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 3 | 0 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 4 | 0 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemochromatosis" by people in Profiles.
-
Association of Hereditary Hemochromatosis With Nonmelanoma Skin Cancer: A Population-Based Nested Case-Control Study. Dermatol Surg. 2024 May 01; 50(5):483-484.
-
Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial. Lancet Gastroenterol Hepatol. 2023 12; 8(12):1118-1128.
-
Structural basis of ferroportin inhibition by minihepcidin PR73. PLoS Biol. 2023 01; 21(1):e3001936.
-
Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 01 01; 29(1):15-25.
-
Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Dig Dis Sci. 2023 01; 68(1):312-322.
-
Applying an Age-specific Definition to Better Characterize Etiologies and Outcomes in Neonatal Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2021 07 01; 73(1):80-85.
-
Iron-Containing Abdominal Pathologies: Exploiting Magnetic Susceptibility Artifact on Dual-Echo Gradient-Echo Magnetic Resonance Imaging. J Comput Assist Tomogr. 2019 Mar/Apr; 43(2):165-175.
-
Adult liver disorders caused by inborn errors of metabolism: review and update. Mol Genet Metab. 2015 Jan; 114(1):1-10.
-
Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis. Mol Genet Metab. 2011 Jul; 103(3):262-7.
-
HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res. 2008 Jul; 152(1):3-10.